[2] MERGA Y, CAMPBELL B J, RHODES J M. Mucosalbarrier, bacteria and inflammatory bowel disease: possibilities for therapy[J]. Digestive Diseases,2014,32(4):475-483.
[3] GIUFFRIDA P, BIANCHERI P, MACDONAID T T. Proteases and small intestinal barrier function in healthand disease[J]. Current Opinion in Gastroenterology,2014, 30(2): 147-153.
[4] SCALDAFERRI F, PIZZOFERRATO M, GERARDI V, et al.The gut barrier: New acquisitions and therapeuticapproaches[J]. Journal of Clinical Gastroenterology, 2012,
46: S12-17.
[5] YAMASHITA T, EMOTO T, SASAKI N, et al. GutMicrobiota and coronary artery disease [J]. Int Heart J,2016, 57(6):663-671.
[6] KLEINE M, WORBS T, SCHREM H, et al. Helicobacterhe-paticus induces an inflammatory response in primaryhuman he-patocytes [J]. PLoS One, 2014, 9(6): e99713-
